American Medical Systems, Inc. Release: First Head-to-Head Study Shows Greenlight XPS® Laser Therapy Equally Safe and Effective With Faster Recovery as Commonly Used Turp for Treatment of BPH

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MINNETONKA, Minn.--(BUSINESS WIRE)--Data presented at the American Urological Association (AUA) Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia (BPH) with GreenLight XPS® laser therapy with MoXy® fiber, instead of transurethral resection of the prostate (TURP), results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.

Help employers find you! Check out all the jobs and post your resume.